Assignee
WYETH LLC
US257 patents
Top patents by PatentIndex Score
US7955605B2Jun 7, 2011
Multivalent pneumococcal polysaccharide-protein conjugate composition
WYETH LLC47 citations97
US7951907B2May 31, 2011
Circovirus sequences associated with piglet weight loss disease (PWD)
WYETH LLC42 citations97
US7888486B2Feb 15, 2011
Antagonist antibodies against GDF-8
WYETH LLC86 citations97
US7709001B2May 4, 2010
Multivalent pneumococcal polysaccharide-protein conjugate composition
WYETH LLC60 citations97
US9669084B2Jun 6, 2017
Pneumococcal dosing regimen
WYETH LLC33 citations96
US8557548B2Oct 15, 2013
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC25 citations96
US7884109B2Feb 8, 2011
Purine and imidazopyridine derivatives for immunosuppression
WYETH LLC58 citations94
US8044178B2Oct 25, 2011
Anti-5T4 antibodies and uses thereof
WYETH LLC41 citations93
US7910107B2Mar 22, 2011
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders
WYETH LLC29 citations93
US7879828B2Feb 1, 2011
Tigecycline compositions and methods of preparation
WYETH LLC16 citations93
US10716848B2Jul 21, 2020
Process for preparing pneumococcal polysaccharide-protein conjugates
WYETH LLC9 citations92
US10597428B2Mar 24, 2020
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC7 citations92
US10406220B2Sep 10, 2019
Pneumococcal dosing regimen
WYETH LLC24 citations92
US9981035B2May 29, 2018
Process for preparing pneumococcal polysaccharide-protein conjugates
WYETH LLC15 citations92
US9745354B2Aug 29, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC15 citations92
USRE46518EAug 22, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC9 citations92
USRE46376EApr 25, 2017
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC9 citations92
US9399060B2Jul 26, 2016
Multivalent pneumococcal polysaccharide-protein conjugate composition
WYETH LLC21 citations92
US9187536B1Nov 17, 2015
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC19 citations92
US8900597B2Dec 2, 2014
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC15 citations92
US8748421B2Jun 10, 2014
Triazine compounds as P13 kinase and MTOR inhibitors
WYETH LLC11 citations92
USRE44768EFeb 18, 2014
Rapamycin hydroxyesters
WYETH LLC46 citations92
US7959927B2Jun 14, 2011
Mycoplasma hyopneumoniae bacterin vaccine
WYETH LLC27 citations92
US7645752B2Jan 12, 2010
Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
WYETH LLC59 citations92
US8956608B2Feb 17, 2015
Method for treating sarcopenia using antagonist antibodies against GDF-8
WYETH LLC16 citations91
US8496934B2Jul 30, 2013
Method for treating cachexia using antagonist antibodies against GDF-8
WYETH LLC13 citations91
US8372625B2Feb 12, 2013
Polynucleotides encoding antagonist antibodies against GDF-8
WYETH LLC16 citations91
US8350013B2Jan 8, 2013
Arginine wash in protein purification using affinity chromatography
WYETH LLC19 citations91
US8039469B2Oct 18, 2011
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC15 citations91
US8022216B2Sep 20, 2011
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
WYETH LLC14 citations91
US7714111B2May 11, 2010
Arginine derivative wash in protein purification using affinity chromatography
WYETH LLC25 citations91
US7838027B2Nov 23, 2010
Pantoprazole multiparticulate formulations
WYETH LLC27 citations90
US8562999B2Oct 22, 2013
Formulations which stabilize and inhibit precipitation of immunogenic compositions
WYETH LLC21 citations89
US8026276B2Sep 27, 2011
Parenteral CCI-779 formulations containing cosolvents, an antioxidant, and a surfactant
WYETH LLC14 citations89
US8002721B2Aug 23, 2011
Thermal covering
WYETH LLC31 citations89
US7935787B2May 3, 2011
Formulations which stabilize and inhibit precipitation of immunogenic compositions
WYETH LLC19 citations89
US7901684B2Mar 8, 2011
Antibodies against human IL-22 and uses therefor
WYETH LLC14 citations89
US7767668B2Aug 3, 2010
Micronized tanaproget, compositions, and methods of preparing the same
WYETH LLC14 citations89
US7758860B2Jul 20, 2010
Protein formulations with reduced viscosity and uses thereof
WYETH LLC44 citations89
US7750122B2Jul 6, 2010
Anti-TrkB monoclonal antibodies and uses thereof
WYETH LLC28 citations89
US7731946B2Jun 8, 2010
Methods and compositions for modulating T helper (TH) cell development and function
WYETH LLC17 citations89
US7713994B2May 11, 2010
Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof
WYETH LLC27 citations88
US11535652B2Dec 27, 2022
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC2 citations84
USRE48863EDec 28, 2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC3 citations84
USRE48862EDec 28, 2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereof
WYETH LLC3 citations84
US11077180B2Aug 3, 2021
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WYETH LLC8 citations84
US10780160B2Sep 22, 2020
Process for preparing pneumococcal polysaccharide-protein conjugates
WYETH LLC4 citations84
US10774117B2Sep 15, 2020
Compositions relating to a mutant clostridium difficile toxin and methods thereof
WYETH LLC6 citations84
US10512681B2Dec 24, 2019
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WYETH LLC12 citations84
US9981045B2May 29, 2018
Multivalent pneumococcal polysaccharide-protein conjugate composition
WYETH LLC13 citations83
Showing the top 50 of 257 patents by PatentIndex Score.